AgomAb Therapeutics NV (AGMB)
10.51
-0.05
(-0.47%)
USD |
NASDAQ |
May 19, 16:00
10.50
-0.02
(-0.14%)
After-Hours: 20:00
AgomAb Therapeutics EPS Diluted (Quarterly) : -0.4156 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| UCB SA | -- |
| AstraZeneca PLC | 0.9849 |
| ANI Pharmaceuticals, Inc. | 1.276 |
| Corcept Therapeutics, Inc. | -0.2988 |
| Assertio Holdings, Inc. | -2.931 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -20.25M |
| Total Expenses (Quarterly) | 20.25M |
| Enterprise Value | 382.23M |
| Earnings Yield | -6.40% |